Accuracy of Apple Watch to Measure Cardiovascular Indices in Patients with Chronic Diseases: A Cross Sectional Study
Alaa Khushhal,Ashraf Mohamed,Mahmoud Elsayed
DOI: https://doi.org/10.2147/jmdh.s449071
2024-03-12
Journal of Multidisciplinary Healthcare
Abstract:Alaa Abdulhafiz Khushhal, 1 Ashraf Abdelaal Mohamed, 1, 2 Mahmoud Elshahat Elsayed 3, 4 1 Department of Medical Rehabilitation Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia; 2 Department of Physical Therapy for Cardiovascular/ Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Cairo, Egypt; 3 Cardiology Department, Umm Al-Qura University Medical Center, Umm Al-Qura University, Makkah, Saudi Arabia; 4 Cardiology Department, Faculty of Medicine, Al Azhar University, Cairo, Egypt Correspondence: Alaa Abdulhafiz Khushhal, Department of Medical Rehabilitation Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia, Tel +966536025182, Email Background: The validity of the Apple Watch to measure the heart rate (HR) and oxygen saturation (Spo 2 ) for patients with chronic diseases such as diabetes mellitus (DM), dyslipidemia, and hypertension is still unclear. Therefore, this study aims to investigate the accuracy of the Apple Watch in measuring the Spo 2 and HR in patients with chronic diseases. Methods: Forty-one patients with chronic diseases, including 20 with hypertension, 10 with diabetes, and 11 with dyslipidemia, completed a cross-sectional study. All participants used the Apple Watch against the Polar chest strap and the pulse oximeter at rest and during moderate intensity exercise sessions to measure HR and the SpO2 at rest for 5 minutes, during exercise for 16 minutes, and followed by 3 minutes of rest. The HR was measured during all previous periods, but evaluation of the Spo 2 included 5 measures, done only before and after exercise, with a minute interval between each measure. Results: Overall, a strong correlation exists between measuring the SpO2 using the Apple Watch against the pulse oximeter (Contec) at rest (r = 0.92, p < 0.001) and after exercise (r = 0.86, p < 0.001) in all patients. The HR had a very strong correlation between the Apple Watch and the Polar chest strap (r = 0.99, p < 0.001) in all patients. There was no significant difference (p = 0.76) between the twenty-seven white and fourteen brown-skinned patients. Conclusion: The Apple Watch is valid to measure the HR and SpO2 in patients with chronic diseases. Clinical Trial Registration No: NCT05271864. Keywords: heart rate, diabetes mellitus, hypertension, dyslipidemia, oxygen saturation Assessment of the heart rate (HR) is an essential variable to determine proper exercise training intensity. 1 Utilization of the gold standard 12-lead electrocardiogram (ECG) is considered the most objective HR assessment procedure. A polar chest strap arises as an alternative to the ECG when it is not accessible to use outside the laboratories. The Polar chest strap proved a valid and reliable instrument when tested against the ECG in healthy subjects 2–4 and patients with cardiac diseases at rest and during training. 5 Monitoring the resting as well as the post-training HRR (heart rate recovery) is essential because it helps predict the cardiopulmonary fitness level as well as the mortality risk among evaluated personnel. 6 Chronic diseases such as diabetes, hypertension, and dyslipidemia are increasing worldwide. 7 Diabetes mellitus is a rapidly growing non-communicable chronic disease worldwide, becoming one of the most alarming health problems in the 21st century. 7 Hypertension prevalence is increasing in the Kingdom of Saudi Arabia (KSA); the rate exceeds 25% among adult Saudi subjects. Monitoring hypertension-related disturbances is an urgent concept to prevent organs damage. 8 Recently, a report showed that the prevalence of hypercholesterolemia among the Saudi population ≥ years old is around 12.5%, with males having a higher rate (56.7%) compared to females, who have a lower rate (43.3%). 9 Diabetes mellitus, hypertension, and dyslipidemia are comorbidity disorders, so this study focused on these groups of diseases. 10 Diabetes mellitus, hypertension and dyslipidemia are comorbidities and risk factors for developing cardiac diseases, so it is important to monitor HR and oxygen saturation (SpO2) in day-to-day monitoring in patients with diabetes mellitus, hypertension, and dyslipidemia to prevent developing cardiac diseases, 10–12 but it is difficult to continue monitoring HR and SpO2 in day-to-day monitoring particularly at home, because these measurements require devices available in hospitals for continuous monitoring, smartwatch could compensate for this difficulty by continuously monitoring HR -Abstract Truncated-
health care sciences & services